ixekizumab (Taltz)

What is ixekizumab, and how does it work?

  • Ixekizumab is an injectable biologic drug that suppresses the immune system and is used for the treatment of psoriasis. It is an antibody that binds to interleukin 17A (IL-17A), a chemical produced by cells in the body that stimulates immune reactions. Scientists believe that psoriasis is caused by an increase in the production of T-lymphocytes in response to the attachment of a stimulant, such as interleukin, to the lymphocyte. Stimulated T-lymphocytes cause skin cells to grow rapidly, and the rapid growth of the skin cells produces the skin plaques of psoriasis. Ixekizumab reduces symptoms of psoriasis (inflammation and excessive production of skin cells) by attaching to IL-17A, preventing it from binding and activating T-lymphocytes.
  • The FDA approved Ixekizumab in March, 2016.

What brand names are available for ixekizumab?

What brand names are available for ixekizumab?

  • Taltz is the brand name for ixekizumab available in the US.

Is ixekizumab available as a generic drug?

  • No, this drug is not available as a generic.

Do I need a prescription for ixekizumab?

  • Yes, you need a prescription for this drug.

What are the uses for ixekizumab?

  • Ixekizumab is approved for treating adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or medications that are absorbed into the blood stream (systemic therapy).

What are the side effects of ixekizumab?

Common side effects include:

  • Injection site reactions
  • Upper respiratory tract infections
  • Nausea
  • Tinea infections

Other important side effects include:

Possible serious side effects include:

Ixekizumab increases the risk of infections. Therefore, patients should be evaluated for a history of latent or active tuberculosis infections. Patients with active tuberculosis infection should not receive Ixekizumab.


Types of Psoriasis: Medical Pictures and Treatments See Slideshow

What is the dosage for ixekizumab?

  • This drug is injected under the skin (subcutaneous injection).
  • The recommended dose is 160 mg (two 80 mg injections) at week 0, followed by 80 mg at weeks 2, 4, 6, 8, 10, and 12, then 80 mg every 4 weeks.

Which drugs or supplements interact with ixekizumab?

  • Live vaccines should not be administered to patients treated with ixekizumab because they may develop active disease from the live viruses contained in the vaccine because of their weakened immune system.
  • Vaccine containing killed virus may not generate an adequate immune response because ixekizumab suppresses the immune system.
  • Ixekizumab may indirectly alter blood levels of warfarin (Coumadin, Jantoven), cyclosporine (Neoral), and other drugs that are metabolized by liver enzymes called CYP450 because the formation of these liver enzymes is affected by the level of interleukins.

Is ixekizumab safe to use during pregnancy or while breastfeeding?

  • Use of ixekizumab in pregnant women has not been adequately evaluated.
  • It is not known if ixekizumab is secreted in breast milk, and, therefore, if there are effects on the nursing infant.

What else should I know about ixekizumab?

What preparations of ixekizumab are available?
  • Solution for injection: 80 mg/ml single-dose prefilled autoinjector or prefilled syringe.
How should I keep ixekizumab stored?
  • This drug should be refrigerated at 2 C - 8 C (36 F - 46 F) and it should not be frozen.
  • The single-dose autoinjector or syringe should be discarded in a puncture-resistant container after use.


Ixekizumab (Taltz) is a prescription medication used to treat moderate to severe psoriatic arthritis. Side effects include upper respiratory tract infections, nausea, reactions at the injection site, rhinitis, hives, influenza, and pinkeye. Drug interactions, dosing, and pregnancy and breastfeeding safety information should be reviewed prior to taking any medication.

Treatment & Diagnosis

Medications & Supplements

Subscribe to MedicineNet's Skin Care & Conditions Newsletter

By clicking "Submit," I agree to the MedicineNet Terms and Conditions and Privacy Policy. I also agree to receive emails from MedicineNet and I understand that I may opt out of MedicineNet subscriptions at any time.

Health Solutions From Our Sponsors

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

FDA Prescribing Information